EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Design, Synthesis and Biological Activity Study of γ-Aminobutyric Acid (GABA) Derivatives Containing Bridged Bicyclic Skeletons as BCAT1 Inhibitors

Wen Luo, Zilu Pan, Xinyuan Zhu, Yan Li, Yong Li, Yudi Zhang, Jiamin Pan, Jian Ding, Hua Xie, Guilong Zhao iD

Molecules · 15.02.2025 · 30 (4) · 904

DOI: 10.3390/molecules30040904 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 15.02.2025. Verfasst von Wen Luo und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China. Hauptthemen laut MEDLINE: gamma-Aminobutyric Acid, Drug Design, 4-Aminobutyrate Transaminase, Antineoplastic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Special Funds of National Natural Science Foundation of China, National Natural Science Foundation of China, Guangdong Basic and Applied Basic Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Branched-chain amino acid aminotransferases (BCATs), existing as the two isoforms BCAT1 and BCAT2, are responsible for the catabolism of branched-chain amino acids (BCAAs) and are highly upregulated and implicated in a diverse range of cancers. BCAT1 inhibitors represent a potential class of therapeutic agents for cancers; however, none have yet progressed to clinical development. Our earlier research identified WQQ-345 as a novel BCAT1 inhibitor featuring a unique bridged bicyclic skeleton and demonstrating both in vitro and in vivo antitumor activity against tyrosine kinase inhibitor (TKI)-resistant lung cancer with high BCAT1 expression. In the present study, we proceeded to modify the structure of WQQ-345 by two-round structure–activity relationship (SAR) exploration, leading to the discovery of a bicyclo[3.2.1]octene-bearing GABA derivative 7. Compound 7 exhibited a 6-fold enhancement in BCAT1 enzymatic inhibitory activity compared to the parent compound WQQ-345 and could effectively suppress the growth of 67R cells that highly expressed BCAT1 and was resistant to third-generation TKIs. GABA derivatives are an important chemical class of BCAT1 inhibitors, and therefore, the findings in the present study represent great progress both in the discovery of potent BCAT1 inhibitors with new chemical structures and in the treatment of cancer resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

gamma-Aminobutyric AcidDrug Design4-Aminobutyrate TransaminaseAntineoplastic AgentsEnzyme InhibitorsHumansStructure-Activity RelationshipCell Line, TumorCell ProliferationMolecular StructureTransaminases

Stichwörter der Autor:innen

BCAT1 inhibitorGABAamino acidbicyclo[3.2.1]octanecancer resistancestructure–activity relationshipthird-generation EGFR TKI

Substanzen

gamma-Aminobutyric Acid4-Aminobutyrate TransaminaseBCAT1 protein, humanAntineoplastic AgentsEnzyme InhibitorsTransaminases

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.
  • Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan 528400, China.
  • Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • University of Chinese Academy of Sciences, Beijing 100049, China.
  • School of Pharmacy, China Pharmaceutical University, Nanjing 211198, China.
  • School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.

ORCID-Profile: Guilong Zhao

Förderung

  • Special Funds of National Natural Science Foundation of China
  • National Natural Science Foundation of China
  • Guangdong Basic and Applied Basic Research Foundation
  • Zhongshan Municipal Natural Science Foundation
  • Creative Research Group of Zhongshan City (Lingnan Pharmaceutical Research and Innovation team)
  • the Project of Shanghai Institute of Materia Medica, Chinese Academy of Sciences
  • Opening Foundation from State Key Laboratory of Drug Research
  • High-level Innovative Research Institute, Department of Science and Technology of Guangdong Province

Zitieren

APA

Luo, W., Pan, Z., Zhu, X., Li, Y., Li, Y., Zhang, Y., Pan, J., Ding, J., Xie, H., & Zhao, G. (2025). Design, Synthesis and Biological Activity Study of γ-Aminobutyric Acid (GABA) Derivatives Containing Bridged Bicyclic Skeletons as BCAT1 Inhibitors. Molecules, 30(4), 904. https://doi.org/10.3390/molecules30040904

Vancouver

Luo W, Pan Z, Zhu X, Li Y, Li Y, Zhang Y, et al. Design, Synthesis and Biological Activity Study of γ-Aminobutyric Acid (GABA) Derivatives Containing Bridged Bicyclic Skeletons as BCAT1 Inhibitors. Molecules. 2025;30(4):904. doi:10.3390/molecules30040904

BibTeX
@article{Luo2025,
  author = {Luo, Wen and Pan, Zilu and Zhu, Xinyuan and Li, Yan and Li, Yong and Zhang, Yudi and Pan, Jiamin and Ding, Jian and Xie, Hua and Zhao, Guilong},
  title = {Design, Synthesis and Biological Activity Study of γ-Aminobutyric Acid (GABA) Derivatives Containing Bridged Bicyclic Skeletons as BCAT1 Inhibitors},
  journal = {Molecules},
  year = {2025},
  volume = {30},
  number = {4},
  pages = {904},
  doi = {10.3390/molecules30040904}
}
Kostenlos starten →